tiprankstipranks
Trending News
More News >
MATERNUS-Kliniken AG (DE:MAK)
XETRA:MAK
Germany Market
Advertisement

MATERNUS-Kliniken AG (MAK) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
MATERNUS-Kliniken AG’s (MAK) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting MATERNUS-Kliniken AG is a Buy.
MATERNUS-Kliniken AG’s (MAK) 20-Day exponential moving average is 1.20, while MATERNUS-Kliniken AG’s (MAK) share price is €1.12, making it a Sell.
MATERNUS-Kliniken AG’s (MAK) 50-Day exponential moving average is 1.26, while MATERNUS-Kliniken AG’s (MAK) share price is €1.12, making it a Sell.

MATERNUS-Kliniken AG (MAK) Pivot Points

Sep 08, 2025, 03:03 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.08
1.09
1.11
1.12
1.14
1.15
1.17
Fibonacci
1.09
1.10
1.11
1.12
1.13
1.14
1.15
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MATERNUS-Kliniken AG (MAK) Moving Averages

Sep 08, 2025, 03:03 AM
Period
Simple
Exponential
MA5
1.12Sell
1.13Sell
MA10
1.17Sell
1.16Sell
MA20
1.21Sell
1.20Sell
MA50
1.24Sell
1.26Sell
MA100
1.36Sell
1.33Sell
MA200
1.43Sell
1.43Sell
MATERNUS-Kliniken AG’s (MAK) 10-Day exponential moving average is 1.16, while MATERNUS-Kliniken AG’s (MAK) share price is €1.12, making it a Sell.
MATERNUS-Kliniken AG’s (MAK) 100-Day exponential moving average is 1.33, while MATERNUS-Kliniken AG’s (MAK) share price is €1.12, making it a Sell.
MATERNUS-Kliniken AG’s (MAK) stock price is €1.12 and MATERNUS-Kliniken AG’s (MAK) 50-day simple moving average is 1.24, creating a Sell signal.
MATERNUS-Kliniken AG’s (MAK) stock price is €1.12 and MATERNUS-Kliniken AG’s (MAK) 100-day simple moving average is 1.36, creating a Sell signal.
MATERNUS-Kliniken AG’s (MAK) stock price is €1.12 and MATERNUS-Kliniken AG’s (MAK) 200-day simple moving average is 1.43, creating a Sell signal.

MATERNUS-Kliniken AG (MAK) Technical Indicators

Sep 08, 2025, 03:03 AM
Name
Value
Implied Action
RSI (14)
39.64
Neutral
STOCH (9,6)
13.31
Buy
STOCHRSI (14)
13.04
Buy
MACD (12,26)
-0.04
Buy
ADX (14)
25.05
Neutral
Williams %R
-82.61
Buy
CCI (14)
-109.60
Buy
ATR (14)
0.05
-
Ultimate Oscillator
49.38
Neutral
ROC
-7.44
Sell
MATERNUS-Kliniken AG’s (MAK) Relative Strength Index (RSI) is 39.64, creating a Neutral signal.
MATERNUS-Kliniken AG’s (MAK) Trend Strength Indicator (ADX) is 25.05, creating a Neutral signal.
MATERNUS-Kliniken AG’s (MAK) Commodity Channel Index (CCI) is -109.60, creating a Buy signal.
MATERNUS-Kliniken AG’s (MAK) Price Rate of Change (ROC) is -7.44, creating a Sell signal.

FAQ

Is MAK a Buy, Hold, or Sell?
Based on MAK’s technical indicators, MAK is a Sell.
    What is MAK’s RSI (14)?
    MAK’s RSI (14) is 39.64, which suggests MAK is a Neutral.
      What is MAK’s MACD?
      MAK’s MACD is -0.04, which suggests MAK is a Buy.
        What is MAK’s 5-day moving average?
        MAK’s 5-day moving average is 1.12, which suggests MAK is a Sell.
          What is MAK’s 20-day moving average?
          MAK 20-day moving average is 1.21, which suggests MAK is a Sell.
            What is MAK’s 50-day moving average?
            MAK’s 50-day moving average is 1.24, which suggests MAK is a Sell.
              What is MAK’s 200-day moving average?
              MAK’s 200-day moving average is 1.43, which suggests MAK is a Sell.
                What is MAK’s Williams % R (14)?
                MAK’s Williams % R (14) is -82.61, which suggests MAK is a Buy.
                  What is MAK’s CCI (14)?
                  MAK’s CCI (14) is -109.60, which suggests MAK is a Buy.
                    What is the share price of MATERNUS-Kliniken AG?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis